Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Investigation into in vitro anti-leishmanial combinations of calcium channel blockers and current anti-leishmanial drugs

Texto completo
Autor(es):
Reimao, Juliana Quero [1] ; Tempone, Andre Gustavo [1]
Número total de Autores: 2
Afiliação do(s) autor(es):
[1] Adolfo Lutz Inst, Dept Parasitol, BR-01246000 Sao Paulo - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: Memórias do Instituto Oswaldo Cruz; v. 106, n. 8, p. 1032-1038, DEC 2011.
Citações Web of Science: 8
Resumo

The need for drug combinations to treat visceral leishmaniasis (VL) arose because of resistance to antimonials, the toxicity of current treatments and the length of the course of therapy. Calcium channel blockers (CCBs) have shown anti-leishmanial activity; therefore their use in combination with standard drugs could provide new alternatives for the treatment of VL. In this work, in vitro isobolograms of Leishmania (Leishmania) chagasi using promastigotes or intracellular amastigotes were utilised to identify the interactions between five CCBs and the standard drugs pentamidine, amphotericin B and glucantime. The drug interactions were assessed with a fixed ratio isobologram method and the fractional inhibitory concentrations (FICs), sum of FICs (Sigma FICs) and the overall mean Sigma FIC were calculated for each combination. Graphical isobologram analysis showed that the combination of nimodipine and glucantime was the most promising in amastigotes with an overall mean Sigma FIC value of 0.79. Interactions between CCBs and the anti-leishmanial drugs were classified as indifferent according to the overall mean Sigma FIC and the isobologram graphic analysis. (AU)

Processo FAPESP: 08/11434-3 - Combinações terapêuticas na leishmaniose visceral: o potencial anti-Leishmania de bloqueadores de canais de cálcio
Beneficiário:Juliana Quero Reimão Dalla Zanna
Linha de fomento: Bolsas no Brasil - Doutorado
Processo FAPESP: 08/09260-7 - Combinações terapêuticas na leishmaniose visceral: o potencial anti-leishmania de bloqueadores de canais de cálcio e o uso de nanoformulações lipossomais
Beneficiário:André Gustavo Tempone Cardoso
Linha de fomento: Auxílio à Pesquisa - Regular